Loading…
Pediatrix Medical Group, Inc. is projected to rise to $37.70 by 2027, a +44% move from its current price of $26.27. MD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $25.85 | $26.27 | $26.70 | +0.01% |
| Jul 13 | $25.68 | $26.28 | $26.89 | +0.03% |
| Jul 14 | $25.56 | $26.28 | $27.03 | +0.04% |
| Jul 15 | $25.45 | $26.29 | $27.15 | +0.06% |
| Jul 16 | $25.36 | $26.29 | $27.26 | +0.07% |
| Jul 17 | $25.27 | $26.29 | $27.36 | +0.09% |
| Jul 18 | $25.19 | $26.30 | $27.45 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $25.19 | $26.30 | $27.45 | +0.10% |
| Week 2 | $24.78 | $26.32 | $27.97 | +0.20% |
| Week 3 | $24.47 | $26.35 | $28.38 | +0.31% |
| Week 4 | $24.21 | $26.38 | $28.74 | +0.41% |
| Week 5 | $23.99 | $26.40 | $29.06 | +0.51% |
| Week 6 | $23.80 | $26.43 | $29.35 | +0.62% |
| Week 7 | $23.63 | $26.46 | $29.63 | +0.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pediatrix Medical Group, Inc. operates in Healthcare and provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company delivers clinical care to babies born prematurely or with complications within NICUs and provides inpatient and office-based care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists and other clinicians.
Its network includes neonatal subspecialists, neonatal nurse practitioners, and other pediatric clinicians, along with pediatric subspecialty care such as pediatric intensivists, hospitalists, and pediatric surgeons. The company also supports hospital services in pediatric emergency, labor and delivery, nursery, and newborn hearing screening programs. It was founded in 1979, is based in Sunrise, Florida, and was formerly known as MEDNAX, Inc., changing its name to Pediatrix Medical Group, Inc.
in July 2022.
Pediatrix Medical Group, Inc. (MD) is a healthcare company with a current price of $27.39 and a market cap of $2.25B, ranking 1940. The stock’s latest technical snapshot shows a bullish tilt in sentiment with RSI at 80.
The 30-day range is $24.55 to $30.56, with the 50-day simple moving average at $23.21 and the 200-day simple moving average at $21.18. Near-term support sits at $21.26 and resistance at $27.39. These levels help frame the current price action within a broader chart context.
Forecasts extend through 2026–2050, showing a neutral view for 2026 with an average price equal to the current level ($27.39) and a bullish path thereafter, culminating in substantial upside by 2050 (avg $521.07 with ROI 1802.4).
A major floor 26.8% below — a decisive break under it would weaken the trend.
The nearest floor, 18.0% below — buyers have tended to step in here.
The nearest ceiling, 4.3% above — a clean break opens room to run.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key MD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.84 | Sell | $26.55 | Sell |
| MA 10 | $26.18 | Buy | $26.12 | Buy |
| MA 20 | $25.08 | Buy | $25.27 | Buy |
| MA 50 | $23.51 | Buy | $23.91 | Buy |
| MA 100 | $22.21 | Buy | $22.79 | Buy |
| MA 200 | $21.39 | Buy | $21.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.28 | Neutral |
| Stoch RSI (14) | 32.57 | Neutral |
| CCI (20) | 67.14 | Neutral |
| Williams %R (14) | -28.94 | Info |
| MACD (12,26,9) | 0.14 | Buy |
| ROC (12) | 10.10 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 71.06 | Neutral |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 3.00 | Buy |
| Ultimate (7,14,28) | 68.11 | Neutral |
| Momentum (10) | 2.16 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 26.96 | Sell |
| ADX (14) | 32.10 | Buy |
| ATR (14) | 0.39 | Info |
Technical sentiment is bullish with RSI14 at 80. The stock trades below the key near-term resistance of $27.39 and above a near-term support of $21.26. The 30-day range spans from $24.55 to $30.56, highlighting recent volatility within a constructive uptrend.
The SMA50 sits at $23.21, above the SMA200 at $21.18, which reinforces the positive short-term momentum. Traders may watch the $27.39 level as a near-term resistance to confirm continued upside or a pause as momentum consolidates.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.82 | $26.27 | $34.95 | 0% | Neutral | |
| $30.87 | $37.70 | $48.13 | +44% | Bullish | |
| $35.57 | $44.25 | $58.02 | +68% | Bullish | |
| $39.05 | $49.32 | $66.05 | +88% | Bullish | |
| $47.32 | $60.58 | $82.57 | +131% | Bullish | |
| $54.71 | $70.89 | $98.17 | +170% | Bullish | |
| $66.58 | $87.25 | $122.53 | +232% | Bullish | |
| $81.47 | $107.89 | $153.48 | +311% | Bullish | |
| $91.09 | $121.83 | $175.38 | +364% | Bullish | |
| $101.66 | $137.25 | $199.78 | +422% | Bullish | |
| $178.53 | $251.39 | $383.48 | +857% | Bullish | |
| $331.37 | $500.45 | $818.29 | +18.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.82 | $26.27 | $31.55 | +0.00% |
| August 2026 | $22.64 | $26.50 | $31.70 | +0.88% |
| September 2026 | $22.63 | $26.62 | $32.09 | +0.46% |
| October 2026 | $23.42 | $27.66 | $33.57 | +3.91% |
| November 2026 | $23.88 | $28.31 | $34.54 | +2.32% |
| December 2026 | $23.97 | $28.51 | $34.95 | +0.70% |
Click any year to see its month-by-month MD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MD is projected to trade between $18.82 and $34.95, averaging $26.27 — a potential gain of 0% from today's $26.27. Price action looks broadly range-bound.
Pediatrix Medical Group, Inc.'s 2027 outlook centres on $37.70, within a $30.87 to $48.13 range. That is up +44% on the projected 2026 average. That marks a +44% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, MD could reach as high as $58.02, with a base case around $44.25 and support toward $35.57 — roughly +68% from $26.27. Momentum favours further upside here.
Expect MD to range from $39.05 to $66.05 through 2029. The $49.32 average target implies a +88% move from current prices. That is up +11% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The MD price prediction for 2030 points to an average of $60.58 (low $47.32, high $82.57) — a potential gain of +131% on today's $26.27. Momentum favours further upside here.
In 2031, MD is projected to trade between $54.71 and $98.17, averaging $70.89 — a potential gain of +170% from today's $26.27. That is up +17% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pediatrix Medical Group, Inc.'s 2032 outlook centres on $87.25, within a $66.58 to $122.53 range. That is up +23% on the projected 2031 average. That marks a +232% change versus current levels. Momentum favours further upside here.
By 2033, MD could reach as high as $153.48, with a base case around $107.89 and support toward $81.47 — roughly +311% from $26.27. Buyers look set to stay in control over this stretch.
Expect MD to range from $91.09 to $175.38 through 2034. The $121.83 average target implies a +364% move from current prices. That is up +13% on the projected 2033 average. Momentum favours further upside here.
The MD price prediction for 2035 points to an average of $137.25 (low $101.66, high $199.78) — a potential gain of +422% on today's $26.27. Buyers look set to stay in control over this stretch.
In 2040, MD is projected to trade between $178.53 and $383.48, averaging $251.39 — a potential gain of +857% from today's $26.27. That is up +83% on the projected 2035 average. Momentum favours further upside here.
Pediatrix Medical Group, Inc.'s 2050 outlook centres on $500.45, within a $331.37 to $818.29 range. That is up +99% on the projected 2040 average. That marks a +18.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MD today (≈ 38.066235 MD) could be worth
$19,050.37
+$18,050.37 (+1805%) by 2050 · US Dollar
Based on the average projected MD price of $500.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MDwould be worth at today's price.
$1,000 invested in MD on Jul 10, 2025 (≈ 74.074074 MD) would be worth
$1,945.93
+$945.93 (+94.6%) today · 1.95× · US Dollar
Based on a MD entry price of $13.5 vs. today's $26.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $26.76 | $981.69 | -1.8% |
| 1 month ago | $23.56 | $1,115.03 | +11.5% |
| 3 months ago | $21.45 | $1,224.71 | +22.5% |
| 6 months ago | $22.66 | $1,159.31 | +15.9% |
| 1 year ago | $13.5 | $1,945.93 | +94.6% |
| All time (5.0y) ago | $29.85 | $880.07 | -12.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MD forecast.
Our base-case forecast reaches $53.00 around 2030.
Implied market cap at $53.00: $4.35B
The multi-year forecast paints a progressively bullish trajectory. In 2026 the average price is $27.39 with a minimum of $18.82 and a maximum of $36.54, and ROI is 0. The outlook improves in 2027, with an average of $39.43, a high of $50.36, and a minimum of $32.29; ROI is 44 and sentiment remains BULLISH.
By 2028 the average rises to $46.03 (min $37.00, max $60.37) with ROI 68.1, and 2029 shows an average of $51.32 (min $40.62, max $68.74) with ROI 87.4.
In 2030 the forecast means an average of $63.45 (min $49.55, max $86.50) and ROI 131.6, followed by 2031 with average $73.90 (min $57.02, max $102.34) and ROI 169.8. The uptrend continues through 2032 at an average of $90.94 (min $69.39, max $127.73) and 2033 at $112.95 (min $85.28, max $160.70).
The path remains bullish through 2034–2035 and beyond, with 2034 average $126.77 and 2035 average $142.72. In 2040 the forecast shows a large step higher to an average of $260.90 (min $185.26, max $398.02) with ROI 852.5, and by 2050 the average is $521.07 (min $345.00, max $852.05) and ROI 1802.4. These figures illustrate a sustained, strong appreciation trajectory under bullish sentiment across the long horizon.
Tap a question to reveal the answer.
The 2030 forecast shows an average of $63.45, a minimum of $49.55, and a maximum of $86.50, with ROI 131.6 and bullish sentiment.
The outlook shifts from neutral in 2026 (avg $27.39, ROI 0) to bullish from 2027 onward, with rising averages and ROI: 2027 avg $39.43 (ROI 44), 2028 avg $46.03 (ROI 68.1), 2029 avg $51.32 (ROI 87.4), continuing toward 2030–2050 where the returns expand dramatically (e.g., 2040 ROI 852.5 and 2050 ROI 1802.4).
Yes. The 2031 max is $102.34 and the 2032 max is $127.73, indicating prices exceeding $100 are projected in those years.
The 2026 forecast shows min $18.82, avg $27.39, max $36.54, with ROI 0 and sentiment Neutral.
In 2040 the average is $260.90 with ROI 852.5, and in 2050 the average is $521.07 with ROI 1802.4, both with bullish sentiment.
Pediatrix Medical Group, Inc. Community Discussion
0Share your Pediatrix Medical Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.